Furthermore, circ_ZNF124 could still be amplified when treated RNA with RNase A before reverse transcription, while GAPDH could not be detected after RNase A treatment, indicating that circ_ZNF124 was stably exist in NSCLC cells (Fig. 1b). Here, RNASE1 is linked to non-small cell lung carcinoma.